New statistics show that people with dementia have been particularly vulnerable during the pandemic.
Academic rigor, journalistic flair
University of Virginia
The University of Virginia is an iconic public institution of higher education, boasting nationally ranked schools and programs, a proud history as a renowned research university and leaders who are well-prepared to help shape the future of the nation and the world.
In 1819, Thomas Jefferson founded UVA and inaugurated a bold experiment – a public university designed to advance human knowledge, educate leaders and cultivate an informed citizenry. Two centuries later, Jefferson’s vision thrives. Across Grounds - and throughout the world - UVA students, faculty, staff and alumni challenge convention, break barriers and pursue the greater good.
Links
Displaying 201 - 220 of 317 articles
The president and first lady Melania Trump have both tested positive for the coronavirus. Here’s what the physicians and scientists know about the best treatments for the disease it causes.
Merasa seperti Anda menghadapi terlalu banyak hal yang tidak diketahui terkait pandemi? Membingkai ulang apa artinya tidak tahu dapat membantu Anda memutuskan hubungan ketidakpastian-kecemasan.
A pediatrician answers parents’ questions about catching up on missed childhood vaccinations and why that’s so important.
When the federal government doesn’t intervene during downturns, the states often cut school spending. In turn, teachers may earn less or lose their jobs. And three in four teachers are female.
Feel like you’re facing too many pandemic-related unknowns? Reframing what it means to not know can help you break the uncertainty-anxiety connection.
Several vaccines are in Phase 3 trials. So when will we know whether any of these will protect against COVID-19?
Couch potatoes are always looking for a way out.
September is Alzheimer’s Awareness Month and therefore a good time to talk about dementia. Alzheimer’s is the most common dementia, but there are others to be aware of, a gerontologist explains.
Por muy sombría que sea la situación con la pandemia que asola el mundo y el creciente número de muertes, hay muchas razones para ser optimistas y confiar en que habrá una vacuna a principios del próximo año.
In the blood of COVID-19 survivors are antibodies that can defeat SARS-CoV-2. Researchers are testing whether these antibodies can be collected and injected into others to save them from the virus.
As grim as things are with the pandemic raging in the US and the mounting death toll, there are many reasons to be optimistic there will be a vaccine by early next year.
A new approach is making a big difference in Virginia.
Una infección crónica o persistente se mantiene durante meses o incluso años, típicamente escondida en áreas del cuerpo poco accesibles para el sistema inmune.
La medicina está evolucionando rápidamente a medida que comprendemos mejor cómo actúa el virus SARS-CoV-2. Ya se están probando decenas de drogas que puedan ayudar a los pacientes con COVID-19.
Some viruses can hide out in the body and reemerge at later times. Which viruses do this, and can the new coronavirus do this too?
A new study shows that while fine particle air pollution has declined nationwide over the past 40 years, the health and environmental benefits haven’t been shared evenly.
Thanks to some serendipity and fortuitous timing, the images emerging out of Selma had a uniquely powerful effect on the nation.
A key difference is people’s behavior, as a doctor explains.
During the last six months, news reports have mentioned dozens of drugs that may be effective against the new coronavirus. Here we lay out the evidence and reveal which ones are proven to work. Or not.
Authors
-
Associate Professor of Hip-Hop, University of Virginia
-
Georgia S. Bankard Professor of Economics, University of Virginia
-
Professor of Emergency Medicine and Pediatrics, University of Virginia
-
Assistant Professor of Computer Science, University of Virginia
-
Professor of Family Medicine and Public Health Sciences, University of Virginia
-
Associate Professor of Public Policy and Economics, University of Virginia
-
Research Assistant Professor of Law, University of Virginia
-
Assistant Professor of Medicine, University of Virginia
-
Assistant Professor of Economics, University of Virginia
-
Associate Professor of Medicine and Geriatrics, University of Virginia
-
Associate Professor of Robotics and Artificial Intelligence, University of Virginia
-
Professor of Public Health Sciences, Director of the Program on Health Disparities and Community Engagement Research, University of Virginia
-
Professor of Law, University of Virginia
-
Professor of Public Policy (retired), University of Virginia
-
Emeritus Professor of Politics, Washington and Lee University; Senior Fellow, Miller Center, University of Virginia
